semaglutide average weight loss in a month Tirzepatide causes more than average weight loss first month

But many people, not understanding this pattern, assumed something was wrong and either changed their approach unnecessarily or became discouraged and stopped trying as hard

The SURMOUNT-1 trial showed participants on 15 mg tirzepatide lost an average of 22.5% of body weight over 72 weeks

Nausea affects approximately 28% of users at higher doses, while diarrhea impacts around 24%

Gentinetta, T

Important Safety Information for Mounjaro (tirzepatide) Injection Warning: Risk of Thyroid C-Cell Tumors Mounjaro (tirzepatide) injection may cause thyroid tumors, including thyroid cancer

Dawn Ericsson, MD, alongside a multidisciplinary team